4.4 Article

Immunogenicity of 56°C and UVC-Treated Prostate Cancer Is Associated With Release of HSP70 and HMGBI From Necrotic Cells

期刊

PROSTATE
卷 69, 期 12, 页码 1343-1352

出版社

WILEY
DOI: 10.1002/pros.20981

关键词

dendritic cells; tumor immunity; cell death; vaccination; antigen presentation

资金

  1. Italian Ministry of University, Regione Piemonte
  2. Compagnia di San Paolo di Torino/FIRM
  3. Compagnia di San Paolo di Genova
  4. Fondazione Cassa di Risparmio di Torino
  5. Fondazione Cariverona
  6. Compagnia di San Paolo

向作者/读者索取更多资源

BACKGROUND. Prostate hyperthermia and photodynamic therapy can be delivered by a variety of procedures which result in a wide range of temperatures and light energy and cause different kinds of cell death. METHODS. We have addressed the immunogenic effect of heating and UVC irradiation on the prostate cancer (PCa) cell line LNCaP, by Studying the release of Danger Associated Molecule Pattern (DAMP) molecules HSP70 and HMGB1 and the dendritic cell (DC) antigen-presenting efficiency. RESULTS. Intracellular upmodulation and extracellular release of HSP70 were inversely correlated. Mild temperatures (43-47 degrees C) induced an earl), increase of intracellular HSP70, whereas the highest temperature (56 degrees C) induced its extrusion from the cell. Likewise, UVC caused an immediate migration of HSP70 into the cell medium ill the absence of any intracellular modulation. 56 degrees C and UVC also induced a robust release of HMGB1. The release of DAMP molecules was closely associated with post-apoptotic membrane damage, as shown by double Annexin V/propidium iodide staining, whereas beta-tubulin, a structural component of cell membranes, was specifically induced by 56 degrees C heating. Tumor uptake strongly impaired the cytokine-driven maturation of DCs and 56 degrees C heating led to a significant recovery of CD83 and CCR7 DC maturation markers, but did not influence the antigen cross-presentation activity. On the contrary, UVC-treated LNCaP had negligible effects on DC maturation, but increased the cross-priming Of tumor specific CTL. CONCLUSIONS. These data may be Of use in the design of effective non-surgical PCa ablations that combine tumor destruction with long lasting immunity. Prostate 69: 1343-1352, 2009. (C) 2009 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据